The Human Medicines Regulations 2012, Paragraph 31 is up to date with all changes known to be in force on or before 04 March 2025. There are changes that may be brought into force at a future date. Changes that have been made appear in the content and are referenced with annotations.
31. In section 130 M1 (meaning of medicinal product and related expressions)—U.K.
(a)for subsection (1) substitute—
“(1) In this Act, “medicinal product” has the meaning given by regulation 2 of the 2012 Regulations.”; and
(b)omit subsections (2) to (8) and (10).
Marginal Citations
M1Section 130(1) was amended by paragraph 66(a) of Part 1 of Schedule 8 to S.I. 2006/2407.
All content is available under the Open Government Licence v3.0 except where otherwise stated. This site additionally contains content derived from EUR-Lex, reused under the terms of the Commission Decision 2011/833/EU on the reuse of documents from the EU institutions. For more information see the EUR-Lex public statement on re-use.
